Cafepharma Today

May 20 2025 - FDA outlines stricter Covid vaccine booster approval standards for healthy people
FDA outlines stricter Covid vaccine booster approval standards for healthy people
AHA warns tariffs could worsen drug shortages, pushes for long-term reform
Surveyed via text, HCPs say they want more interactions with pharma
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca notes that Pfizer does not intend to make an offer
The Fly on the Wall
Monday, May 26, 2014 - 6:08pm
tags:
Pfizer, AstraZeneca, M&A
Celldex After CDX-1135 - What's The Outlook?
Seeking Alpha
Monday, May 26, 2014 - 8:39am
tags:
Celldex, CDX-1135
Novartis MS Drug Helps Traumatic Memories Fade in Mice
Bloomberg
Monday, May 26, 2014 - 8:35am
tags:
Novartis, PTSD, post traumatic stress disorder, Gilenya
Pfizer Said on Verge of Abandoning AstraZeneca Offer
Bloomberg
Monday, May 26, 2014 - 8:33am
tags:
Pfizer, M&A, AstraZeneca
AstraZeneca on brink of victory as Pfizer deadline set to expire
The Telegraph, UK
Sunday, May 25, 2014 - 10:36am
tags:
AstraZeneca, Pfizer, M&A
Is Merck Poised to Head Higher?
Wall St Cheat Sheet
Sunday, May 25, 2014 - 10:31am
tags:
Merck
The Future of Fat Fighting: Next-Gen Obesity Drugs
Motley Fool
Sunday, May 25, 2014 - 10:30am
tags:
obesity, weight loss, Zafgen, beloranid, Arena, Vivus, Qsymia, Belviq
3 Breakthrough Drugs Yield 1 Instant Blockbuster
Motley Fool
Sunday, May 25, 2014 - 10:26am
tags:
Roche, Gazyva, Imbruvica, JNJ, Gilead Sciences, Sovaldi, mantle cell lymphoma, chronic lymphocytic leukemia, leukemia, Biogen, hepatitis, hepatitus C
BioCryst to Announce Results From the BCX4161 OPuS-1 Phase 2 Trial for Hereditary Angioedema May 27
Yahoo/Globe Newswire
Sunday, May 25, 2014 - 10:22am
tags:
Biocryst, BCX4161, angioedema
Healthcare Companies Have Significant Opportunity to Gain Customer Loyalty of Hispanics, Reports PwC's Health Research Institute
Insurance News Net
Saturday, May 24, 2014 - 10:18am
tags:
Affordable Care Act
Insider Selling: John K. Clarke Sells 35,000 Shares of Alnylam Pharmaceuticals Stock (ALNY)
WKRB13
Saturday, May 24, 2014 - 10:14am
tags:
Alnylam
Pfizer Is A Buy Below $30
Seeking Alpha
Saturday, May 24, 2014 - 10:02am
tags:
Pfizer
Pfizer, BioRestorative Therapies Ink Deal
Yahoo/Zacks
Saturday, May 24, 2014 - 9:59am
tags:
Pfizer, brown adipose tissue, BioRestorative Therapies
Here’s What Happens If AstraZeneca and Pfizer Miss Their Deal Deadline (video)
The Street
Saturday, May 24, 2014 - 9:57am
tags:
AstraZeneca, Pfizer, M&A
Provectus Biopharmaceuticals Inc. Reaffirms Its Commitment to Bringing PV-10 to Market Notwithstanding FDA Decision on Breakthrough Therapy Designation
Yahoo/BusinessWire
Saturday, May 24, 2014 - 9:54am
tags:
Provectus, melanoma, PV-10
Better Bad News Buy: Ariad Pharmaceuticals vs. Exelixis
Motley Fool
Saturday, May 24, 2014 - 9:50am
tags:
Ariad Pharmaceuticals, Exelixis
Amgen gets expanded approval for colon cancer drug
Yahoo/AP
Saturday, May 24, 2014 - 9:49am
tags:
Amgen, colon cancer, Vectibix
ZIOPHARM Presents Encouraging Data
Yahoo/Zacks
Saturday, May 24, 2014 - 9:46am
tags:
Ziopharm, Ad-RTS-IL-1, brain cancer
FDA Approves Durata Therapeutics' DALVANCE(TM) for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Caused by Susceptible Gram-Positive Bacteria, Including MRSA, in Adults
Yahoo/Globe Newswire
Saturday, May 24, 2014 - 9:44am
tags:
Durata Therapeutics, Dalvance, MRSA, skin infection
Teva Doomsday Scenario Seen Averted as Patients Switch
Bloomberg
Friday, May 23, 2014 - 7:09am
tags:
Teva Pharmaceuticals, Copaxone

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.